Drugs Approved for Malignant Mesothelioma

Pemetrexed
Ipilimumab
Nivolumab

Drugs Approved for Melanoma

Aldesleukin
Binimetinib
Bravtovi
Cobimetinib
Dabrafenib
Dacarbazine
Encorafenib
Imlygic
Interferon
Ipilimumab
Nivolumab
Pembrolizumab
Talimogene Laherparepvec
Trametinib
Vemurafenib

Drugs Approved for Multicentric Castleman Disease

Siltuximab

Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms

Belantamab Mafodotin-blmf
Bortezomib
Carfilzomib
Carmustine
Cyclophosphamide
Daratumumab
Daratumumab and Hyaluronidase-fihj
Elotuzumab
Isatuximab-irfc
Ixazomib
Lenalidomide
Melphalan
Melphalan flufenamide
Pamidronate
Panobinostat
Plerixafor
Pomalidomide
Selinexor
Thalidomide
Zoledronic Acid

Drugs Approved for Myeloproliferative Neoplasms

Arsenic Trioxide
Azacitidine
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin
Decitabine
Doxorubicin
Fedratinib
Imatinib Mesylate
Nilotinib
Ruxolitinib

Drugs Approved for Neuroblastoma

Cyclophosphamide
Dinutuximab
Doxorubicin
Vincristine

Drugs Approved for Non-Hodgkin’s Lymphoma

Acalabrutinib
Belinostat
Bendamustine
Bleomycin
Bortezomib
Brentuximab Vedotin
Brexucabtagene Autoleucel
Carmustine
Chlorambucil
Copanlisib
Cyclophosphamide
Denileukin Diftitox
Dexamethasone
Doxorubicin
Duvelisib
Ibritumomab
Ibrutinib
Idelalisib
Interferon
Loncastuximab tesirine
Lenalidomide
Methotrexate
Mogamulizumab-kpkc
Nelarabine
Obinutuzumab
Pembrolizumab
Plerixafor
Polatuzumab Vedotin-piiq
Pralatrexate
Prednisone
Rituximab
Romidepsin
Selinexor
Tafasitamab-cxix
Tazemetostat Hydrobromide
Tisagenlecleucel
Umbralisib
Venetoclax
Vinblastine
Vincristine
Vorinostat
Zanubrutinib

Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Bevacizumab
Carboplatin
Cisplatin
Cyclophosphamide
Doxorubicin
Gemcitabine
Melphalan
Niraparib
Olaparib
Paclitaxel
Rucaparib
Thiotepa
Topotecan

Drugs Approved for Pancreatic Cancer

Erlotinib
Everolimus
Fluorouracil
Gemcitabine
Irinotecan
Mitomycin
Olaparib
Paclitaxel
Sunitinib
Tarceva

Drugs Approved for Penile Cancer

Bleomycin

Drugs Approved for Prostate Cancer

Abiraterone
Apalutamide
Bicalutamide
Cabazitaxel
Darolutamide
Degarelix
Docetaxel
Enzalutamide
Flutamide
Goserelin
Leuprolide
Mitoxantrone
Nilutamide
Olaparib
Rucaparib
Sipuleucel-T

Drugs Approved for Retinoblastoma

Cyclophosphamide

Drugs Approved for Rhabdomyosarcoma

Dactinomycin
Vincristine

Drugs Approved for Melanoma

Aldesleukin
Cobimetinib
Dabrafenib
Dacarbazine
Interferon
Ipilimumab
Nivolumab
Pembrolizumab
Talimogene Laherparepvec
Trametinib
Vemurafenib

Drugs Approved for Merkel Cell Carcinoma

Avelumab
Pembrolizumab

Drugs Approved for Basal Cell Carcinoma

Fluorouracil
Imiquimod
Sonidegib
Vismodegib

Drugs Approved for Cutaneous Squamous Cell Carcinoma

Cemiplimab-rwlc
Pembrolizumab

Drugs Approved for Soft Tissue Sarcoma

Dactinomycin
Doxorubicin
Eribulin
Imatinib
Pazopanib
Tazemetostat
Trabectedin

Drugs Approved for Stomach Cancer

Docetaxel
Doxorubicin
Fluorouracil
Mitomycin
Pembrolizumab
Ramucirumab
Trastuzumab
Trifluridine and Tipiracil

Drugs Approved for Testicular Cancer

Bleomycin
Cisplatin
Dactinomycin
Etoposide
Ifosfamide
Vinblastine

Drugs Approved for Thyroid Cancer

Cabozantinib
Dabrafenib
Doxorubicin
Lenvatinib
Selpercatinib
Sorafenib
Trametinib
Vandetanib

Drugs Approved for Vulvar Cancer

Bleomycin

Drugs Approved for Wilms Tumor

Dactinomycin
Doxorubicin
Vincristine

Other Cancers

Medicines Approved for Specific Cancers (A-D)

Medicines Approved for Specific Cancers (E-L)

Chemo agents for specific cancers in PDF format.

Systemic Treatment of Cancer